Belgica SPRL
Belgica reported total assets of 567,720 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Belgica shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +62 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Belgica's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 88,044 € | ||||
| Equity | 265,033 € | ||||
| Cash | 278,810 € | ||||
| EBITDA | 145,070 € | ||||
| Total assets | 567,720 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 29 Dec 2024
- Year ended 31 Dec 2022filed on 31 Dec 2023
- Year ended 31 Dec 2021filed on 10 Apr 2023
Belgica's financial analysis
- Solvency46.7%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Belgica
Belgica's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0406.183.342
- VAT number
- BE0406183342
- Peppol
- Registered · 0208:0406183342 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 23 Sep 1968
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Belgica (SPRL) has been based in Ghent since 1968, active in: manufacture of other pharmaceutical products. For 2025, it reports a net profit of 88,044 € and equity of 265,033 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Belgica
Companies in the same business, of comparable size and area, outside its group.
- Thameus Manufacture of pharmaceutical preparations Liège · balance sheet 502,659 €
- Prieka Manufacture of pharmaceutical preparations Etterbeek · balance sheet 440,325 €
- Parabolic Biologicals Manufacture of pharmaceutical preparations Namur · balance sheet 132,669 €
- NAQI Manufacture of pharmaceutical preparations Halen · balance sheet €1.25m
- AdipoPharma Belgique Manufacture of pharmaceutical preparations Charleroi · balance sheet 398,195 €
- -Heel Belgium Manufacture of pharmaceutical preparations Ghent · balance sheet €3.17m
- Orca Consulting Manufacture of pharmaceutical preparations Kapellen · balance sheet 347,741 €
- Unda Manufacture of pharmaceutical preparations Aywaille · balance sheet 517,605 €
Frequently asked questions about Belgica
What is the revenue of Belgica?
Belgica files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Belgica?
In Belgium, the VAT number is the company number prefixed with BE: BE0406183342 for Belgica, if the company is VAT-registered. Its company number (CBE) is 0406.183.342.
Where is the registered office of Belgica?
According to the CBE register, the registered office of Belgica is in 9000 Ghent.
What is the equity of Belgica?
At the close of the 2025 financial year, the equity of Belgica amounts to 265,033 €, a solvency of 46.7% of total assets.
Who manages Belgica?
The register lists 1 active mandates at Belgica. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Belgica
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →